Par Health Issues Voluntary Nationwide Recall of Two Lots of Brevital® Sodium 500 mg/vial CIV (Methohexital Sodium for Injection, USP) Due to the Presence of Particulate Matter
- Date
- Oct 8, 2026
- Company
- Par Health
- Brand
- Par Pharmaceutical
- Product
- Brevital Sodium 500 mg/vial for Injection
- Reason
- Presence of particulate matter identified as cellulose
- Hazard
- Other
- Source
- FDA
How to identify the product
- Brevital® Sodium 500 mg/vial CIV (Methohexital Sodium for Injection, USP), Distributed by: Par Pharmaceutical*
- These lots were distributed nationwide to wholesalers between July 8, 2025 and May 11, 2026.
- Par Health is providing written notification to wholesale accounts that have received the affected lots and are arranging for return of all existing inventory of Lots 86930 and 88623 through Inmar, Inc.
- If you have further distributed the recalled product, please notify your accounts or any additional locations which may have received the recalled product.
Product photos are on the official FDA page.
Facts are taken from the official notice. If anything here differs from it, the official notice is correct.